ESR1 and breast cancer: AR signalling influence on breast cancer depends on the contest of the different subtype of disease [3] as indicated by a number of studies showing that the expression of AR is a favourable determinant of survival in estrogen receptor alpha (ERα)-positive, but not ERα-negative breast cancer patients [7–9].